1.

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

2.

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

3.

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

1.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

2.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

3.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

4.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

5.

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands